{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:41:34Z","timestamp":1784673694267,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.brachy.2025.03.005","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:55:38Z","timestamp":1747338938000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Choosing between the best, the easiest and the most usual: Three different dose prescription methods for HDR vaginal-cuff brachytherapy planning in postoperative endometrial cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Faegheh","family":"Noorian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Herreros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Abellana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Baltrons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4891-3784","authenticated-orcid":false,"given":"Cristian","family":"Candela-Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Agull\u00f3-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Noorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-334X","authenticated-orcid":false,"given":"\u00c1ngeles","family":"Rovirosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brachy.2025.03.005_bib0001","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1002\/hsr2.1835","article-title":"The global incidence, mortality, and burden of uterine cancer in 2019 and correlation with SDI, tobacco, dietary risks, and metabolic risk factors: an ecological study","volume":"7","author":"Mazidimoradi","year":"2024","journal-title":"Health Sci Rep"},{"key":"10.1016\/j.brachy.2025.03.005_bib0002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecolog Cancer"},{"issue":"4","key":"10.1016\/j.brachy.2025.03.005_bib0003","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cancers14040906","article-title":"Role of brachytherapy in the postoperative management of endometrial cancer: decision-making analysis among experienced European radiation oncologists","volume":"14","author":"Glatzer","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.005_bib0004","first-page":"42","article-title":"Treatment planning and optimization in high-dose-rate brachytherapy","volume":"1","author":"Reddy","year":"2013","journal-title":"J Cancer Res Treatment"},{"issue":"5","key":"10.1016\/j.brachy.2025.03.005_bib0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5114\/jcb.2024.144183","article-title":"Where are we with fractionation schedules and prescriptions in high-dose-rate 3D planning vaginal cuff brachytherapy?","volume":"16","author":"Rovirosa","year":"2024","journal-title":"J Contemp Brachytherapy"},{"issue":"6","key":"10.1016\/j.brachy.2025.03.005_bib0006","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5114\/jcb.2020.101694","article-title":"Adjuvant vaginal cuff brachytherapy: Dosimetric comparison of conventional versus 3-dimensional planning in endometrial cancer","volume":"12","author":"Gultekin","year":"2021","journal-title":"J Contemp Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.005_bib0007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.prro.2022.09.002","article-title":"Radiation therapy for endometrial cancer: an American Society for Radiation Oncology Clinical Practice Guideline","volume":"13","author":"Harkenrider","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.03.005_bib0008","first-page":"189","article-title":"Are 7.5 Gy\u00d72 fractions more efficient than 6 Gy\u00d73 in exclusive postoperative endometrial cancer brachytherapy? A clinical and dosimetrical analysis","volume":"1","author":"Noorian","year":"2023","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.brachy.2025.03.005_bib0009","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/jpm14080838","article-title":"Impact of vaginal dilator use and 68 Gy EQD2(\u03b1\/\u03b2=3) dose constraint on vaginal complications in external beam irradiation followed by brachytherapy in post-operative endometrial cancer","volume":"14","author":"Noorian","year":"2024","journal-title":"J Pers Med"},{"issue":"6","key":"10.1016\/j.brachy.2025.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s12094-023-03099-4","article-title":"Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2 late vaginal complications in 3D vaginal cuff brachytherapy (interventional radiotherapy)?","volume":"25","author":"Zhang","year":"2023","journal-title":"Clin Translation Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.005_bib0011","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5114\/jcb.2018.74140","article-title":"Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction(\u03b1\/\u03b2=3Gy) at 2 cm3 of vagina","volume":"10","author":"Del Valle Aguilera","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2025.03.005_bib0012","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynecologic HDR brachytherapy\u2014an American Brachytherapy Society Task Group Report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.03.005_bib0013","first-page":"13","article-title":"IMRT and brachytherapy comparison in gynaecological cancer treatment: Thinking over dosimetry and radiobiology","volume":"17","author":"Pinzi","year":"2019","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.005_bib0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/0971-6203.139015","article-title":"Dose optimization in gynecological 3D image based interstitial brachytherapy using martinez universal perineal interstitial template (MUPIT) -an institutional experience","volume":"39","author":"Sharma","year":"2014","journal-title":"J Med Phys"},{"issue":"4","key":"10.1016\/j.brachy.2025.03.005_bib0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5114\/jcb.2010.19497","article-title":"A detailed dosimetric comparison between manual and inverse plans in HDR intracavitary\/interstitial cervical cancer brachytherapy","volume":"2","author":"Trnkov\u00e1","year":"2010","journal-title":"J Contemp Brachytherapy"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.005_bib0016","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0360-3016(02)04578-9","article-title":"Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma","volume":"56","author":"Routledge","year":"2003","journal-title":"Int J Radiation Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.005_bib0017","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-8140(95)97448-M","article-title":"EORTC late effects working group Late effects toxicity scoring: the SOMA scale","volume":"35","author":"Pavy","year":"1995","journal-title":"Radiother Oncol"},{"issue":"155","key":"10.1016\/j.brachy.2025.03.005_bib0018","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.radonc.2020.10.038","article-title":"Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer","volume":"1","author":"Wortman","year":"2021","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.005_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.rpor.2020.01.002","article-title":"Postoperative endometrial carcinoma treated with external beam irradiation plus vaginal-cuff brachytherapy. Is there a dose relationship with G2 vaginal complications?","volume":"25","author":"Zhang","year":"2020","journal-title":"Rep Practical Oncol Radiother"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.005_bib0020","doi-asserted-by":"crossref","first-page":"E346","DOI":"10.1016\/j.ijrobp.2019.06.1762","article-title":"Prognostic determinants of salvage image-guided brachytherapy for vaginal recurrence of endometrial cancer","volume":"105","author":"Alban","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.03.005_bib0021","article-title":"Preliminary results of adjuvant image-guided vaginal brachytherapy alone for early stage endometrial carcinoma","volume":"54","author":"Muangwong","year":"2024","journal-title":"Gynecol Oncol Rep"},{"issue":"4","key":"10.1016\/j.brachy.2025.03.005_bib0022","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5114\/jcb.2019.87145","article-title":"Dosimetric comparison of graphical optimization and inverse planning simulated annealing for brachytherapy of cervical cancer","volume":"11","author":"Tang","year":"2019","journal-title":"J Contemp Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.005_bib0023","first-page":"314","article-title":"Dosimetric impact of planning techniques on EQD2 and management of OARs doses in intracavitary brachytherapy in cervical cancer","volume":"38","author":"Marjara","year":"2023","journal-title":"Turk Onkoloji Dergisi"},{"issue":"4","key":"10.1016\/j.brachy.2025.03.005_bib0024","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.net.2021.10.004","article-title":"Variation of optimization techniques for high dose rate brachytherapy in cervical cancer treatment","volume":"54","author":"Azahari","year":"2022","journal-title":"Nucl Engineer Technol"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.005_bib0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijrobp.2005.09.028","article-title":"Conformity index: a review","volume":"64","author":"Feuvret","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.005_bib0026","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.radonc.2018.04.009","article-title":"ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as accelerated partial breast irradiation alone or as boost\u2014GEC-ESTRO Breast Cancer Working Group practical recommendations","volume":"128","author":"Strnad","year":"2018","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.005_bib0027","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.brachy.2022.12.008","article-title":"Validation of automated post-adjustments of HDR prostate brachytherapy treatment plans by quantitative measures and oncologist observer study","volume":"22","author":"Dohlmar","year":"2023","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.005_bib0028","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5114\/jcb.2021.103588","article-title":"An audit of high dose-rate prostate brachytherapy treatment planning at six Swedish clinics","volume":"13","author":"Dohlmar","year":"2021","journal-title":"J Contemp Brachyther"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.005_bib0029","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00066-021-01867-1","article-title":"The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry","volume":"198","author":"Major","year":"2022","journal-title":"Strahlentherapie und Onkologie"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.005_bib0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.5114\/jcb.2020.96865","article-title":"Dosimetric evaluation of vaginal cuff brachytherapy planning in cervical and endometrial cancer patients","volume":"12","author":"Sikorska","year":"2020","journal-title":"J Contemp Brachytherapy"},{"issue":"9","key":"10.1016\/j.brachy.2025.03.005_bib0031","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2025.03.005_bib0032","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5114\/jcb.2012.30679","article-title":"Clinical Investigations dosimetry and toxicity outcomes in postoperative high-dose-rate intracavitary brachytherapy for endometrial carcinoma","volume":"3","author":"Donnelly","year":"2012","journal-title":"J Contemp Brachyther"},{"key":"10.1016\/j.brachy.2025.03.005_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/125020","article-title":"Treatment planning methods in high dose rate interstitial brachytherapy of carcinoma cervix: a dosimetric and radiobiological analysis","volume":"2014","author":"Anbumani","year":"2014","journal-title":"ISRN Oncol"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.005_bib0034","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/acm2.13132","article-title":"The clinical impact of removing rectal gas on high-dose-rate brachytherapy dose distributions for gynecologic cancers","volume":"22","author":"Vergalasova","year":"2021","journal-title":"J Appl Clin Med Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:13:22Z","timestamp":1751397202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125000741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1538472125000741"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.03.005","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Choosing between the best, the easiest and the most usual: Three different dose prescription methods for HDR vaginal-cuff brachytherapy planning in postoperative endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}